ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2771 • 2014 ACR/ARHP Annual Meeting

    PET-CT Imaging and Association of Ferritin Autoantibodies in Polymyalgia Rheumatica

    Niklas Thomas Baerlecken1, Torsten Witte2, Marco Amedeo Cimmino3 and Dario Camellino4, 1Clinical Immunology and Rheumatology, MD, Hannover, Germany, 2Medical School Hannover, MD, Hanover, Germany, 3Clinica Reumatologica, Università di Genova, Genova, Italy, 4Dipartimento Medicina Interna, Clinica Reumatologica, Genova, Italy

    Background/Purpose Previously we described antibodies against ferritin heavy chain peptide (anti-FHCP) in sera of patients with giant cell arteritis (GCA) and/or polymyalgia rheumatic (PMR) before…
  • Abstract Number: 2772 • 2014 ACR/ARHP Annual Meeting

    The Use of Imaging in the Diagnosis of Polymyalgia Rheumatica: Systematic Literature Review and Meta-Analysis

    Sarah Mackie1, Gouri Koduri2, Catherine L. Hill3,4, Andrew Hutchings5, Richard J. Wakefield6, Bhaskar Dasgupta7 and Jeremy Wyatt8, 1NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom, 2Rheumatology, York Teaching Hospital NHS Foundation Trust, York, United Kingdom, 3Rheumatology Unit, The Queen Elizabeth Hospital, Woodville, Australia, 4Discipline of Medicine, University of Adelaide, Adelaide, Australia, 5Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom, 6NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 7Department of Rheumatology, Southend University Hospital, Essex, United Kingdom, 8Leeds Insitute of Health Sciences, University of Leeds, Leeds, United Kingdom

    Background/Purpose ACR/EULAR provisional classification criteria for polymyalgia rheumatica (PMR) incorporate musculoskeletal ultrasound of shoulder and hip (bursitis and synovitis given equal weight). Our objective was…
  • Abstract Number: 2773 • 2014 ACR/ARHP Annual Meeting

    Whole-Body MRI Reveals Characteristic Extracapsular Pattern of Inflammation in Polymyalgia Rheumatica

    Sarah Mackie1, Colin T. Pease2, Eiki Fukuba3, Paul Emery4, Richard J. Hodgson4, Jane E. Freeston5 and Dennis McGonagle6, 1NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom, 2Department of Rheumatology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 3Department of Radiology, Faculty of Medicine, Shimane University, Shimane, Japan, 4NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 5NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds., United Kingdom, Leeds, United Kingdom, 6Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

    Background/Purpose Polymyalgia rheumatica (PMR) is a disease of widespread musculoskeletal inflammation characterized by pain and stiffness in shoulder and hip girdles. Here we report the…
  • Abstract Number: 2736 • 2014 ACR/ARHP Annual Meeting

    Female Specific Increase in T Cell Glycosylation in Lupus

    Gabriela Gorelik1 and Bruce Richardson2, 1Internal Medicine, University of Michigan, Ann Arbor, MI, 2Rheumatology, University of Michigan, Ann Arbor, MI

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is an autoimmune inflammatory disease characterized by altered T cell signaling. SLE is characterized by epigenetic mechanisms that cause hypomethylation…
  • Abstract Number: 2735 • 2014 ACR/ARHP Annual Meeting

    Association of a-Kinase Anchoring Protein-79 (AKAP79) to PKC Mediates Inhibition of IL2 Transcription and Erk Activation in T Cells

    Gabriel Criado1, María J. Pérez-Lorenzo1, María Galindo2, Jose L. Pablos2 and Abel Suarez-Fueyo1, 1Grupo de Enfermedades Inflamatorias y Autoinmunes, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain, 2Servicio de Reumatología, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain

    Background/Purpose A-Kinase anchoring Protein AKAP79 associates to and regulates the activity of PKA, PKC and calcineurin, key regulators of T cell activation. We have previously…
  • Abstract Number: 2734 • 2014 ACR/ARHP Annual Meeting

    B55β Regulates T Cell Survival through the Modulation of AKT during Cytokine Deprivation

    José C. Crispin1, Sokratis A. Apostolidis2, Noe Rodriguez Rodriguez1, Tran Nguyen2 and George C. Tsokos3, 1Medicine/Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 2Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 3Rheumatology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA

    Background/Purpose . The abundance of cytokines controls the length of immune responses through poorly defined mechanisms. B55β is a molecule that triggers apoptosis in activated…
  • Abstract Number: 2737 • 2014 ACR/ARHP Annual Meeting

    Microrna-155 Suppresses IL-21 Signaling and Production in Systemic Lupus Erythematosus

    Tue K. Rasmussen1, Thomas Andersen1, Rasmus Bak1, Gloria Yiu2, Kristian Steengaard-Petersen3, Jacob G. Mikkelsen1, Paul J. Utz4, Christian Holm1 and Bent Deleuran3,5, 1Department of Biomedicine, Aarhus University, Aarhus C, Denmark, 2Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 3Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 4Medicine, Stanford University School of Medicine, Stanford, CA, 5Department of Biomedicine, Aarhus University, Aarhus, Denmark

    Background/Purpose IL-21 is a key regulator of B cells functions and autoantibody production and is mainly produced by follicular T helper cells. The purpose of…
  • Abstract Number: 2738 • 2014 ACR/ARHP Annual Meeting

    Shk-186, a Kv1.3 channel inhibitor That Targets Effector Memory T Cells: Safety and Tolerability in Humans and Its Evaluation in a Model of Rapidly Progressive Glomerulonephritis

    Ernesto J. Muñoz-Elías1, Kayla Norton1, John B. Grigg1, Liz Bromley1, David W. Peckham1, Eric J. Tarcha1, Jared Odegard2, James Qin2, Megan Yuasa3, Anne Stevens4, Wayel H. Abdulahad5, Galina Schmunk6, K. George Chandy6 and Shawn P. Iadonato1, 1Kineta Inc., Seattle, WA, 2Benaroya Research Institute at Virginia Mason, Seattle, WA, 3Seattle Children's Res Institute, Seattle Children's Research Institute, Seattle, WA, 4Seattle Children's Res Inst, Seattle Children's Hospital, Seattle, WA, 5Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, 6Department of Physiology, Biophysics, and Surgery, UC Irvine, Irvine, CA

    Background/Purpose: The voltage-gated potassium channel Kv1.3 is a novel target for the treatment of autoimmune disorders including psoriatic and rheumatic diseases. ShK-186 is an exquisitely specific,…
  • Abstract Number: 2739 • 2014 ACR/ARHP Annual Meeting

    SHP-1 Regulates the Activation Threshold of iNKT Cells

    Meng Zhao1,2 and Mitchell Kronenberg3, 1Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 2Medicine, UC-San Diego, La Jolla, CA, 3La Jolla Institute for Allergy and Immunology, La Jolla, CA

    Background/Purpose Autoreactive invariant Natural Killer T (iNKT) cells have been implicated in several rheumatic diseases, including Systemic lupus erythematosus and Rheumatoid arthritis. iNKT cells are…
  • Abstract Number: 2740 • 2014 ACR/ARHP Annual Meeting

    Microbiota Modulate Intraepithelial Lymphocyte Presence and Function

    Kristine A. Kuhn and Sean P. Colgan, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose: Microbiome studies in autoimmune diseases including rheumatoid arthritis and inflammatory bowel disease demonstrate alterations in relative abundance of specific bacterial species (dysbiosis). The immunologic…
  • Abstract Number: 2741 • 2014 ACR/ARHP Annual Meeting

    The Role of Fli1 in Lupus T Cell Function and Nephritis

    Thirumagal Thiyagarajan1, Ivan Molano2 and Tamara K. Nowling3, 1Medicine, Medical University of South Carolina, Charleston, SC, 2Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, 3Medicine/Rheumatology, Medical University of South Carolina and Ralph H. Johnson VA Medical Center, Charleston, SC

    Background/Purpose: The Ets factor Fli1 is implicated as a key modulator of lupus disease expression. Over-expressing Fli1 in healthy mice, results in the development of…
  • Abstract Number: 2742 • 2014 ACR/ARHP Annual Meeting

    Polymorphisms in the Slam Family of Molecules Play a Role in the Development and Function of Invariant Natural Killer T Cells in New Zealand Black Mice

    Yuriy Baglaenko1, Kieran Manion1, Nan-Hua Chang2 and Joan E. Wither3, 1Immunology, University of Toronto, Toronto, ON, Canada, 2Genetics and Development, Toronto Western Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 31E420/Div of Rheumatology, Toronto Western Research Institute, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada

    Background/Purpose: The family of signaling lymphocyte activating molecules (SLAM) have been shown to play a key role in the development of autoimmunity in spontaneous and…
  • Abstract Number: 2743 • 2014 ACR/ARHP Annual Meeting

    CD27 Is a Key Regulator of T Cell Responses

    Michael Scully1, Nicole Wunderler2, Holger Babbe1, Yevgeniya Orlovsky2, Galina Obmolova3, Ann Cai1, Heath Guay4, Jacqueline Benson4 and Tatiana Ort1, 1Research Immunology, Immunology Research, Janssen Research and Development, LLC, Spring House, PA, 2Immunology Research, Janssen Research and Development, LLC, Spring House, PA, 3Biologics Research, Janssen Research and Development, LLC, Spring House, PA, 4Estrela Lupus Venture, Janssen Research and Development, LLC., Spring House, PA

    Background/Purpose: CD27 is a member of the TNF superfamily of receptors that is expressed on a majority of natural killer (NK) cells, T cells, memory…
  • Abstract Number: 2744 • 2014 ACR/ARHP Annual Meeting

    Mi-RNA Profile of Active Vascular BEHÇET’S Patients

    Ahmet Mesut Onat1, Ozan Gerenli2, Bunyamin Kisacik1, Mustafa Ulasli3, Gezmis Kimyon4, Yavuz Pehlivan5 and Serdar Oztuzcu6, 1Rheumatology, Gaziantep University School of Medicine, Gaziantep, Turkey, 2Rheumatology, Gaziantep UniversitySchool of Medicine, Gaziantep, Turkey, 3Genetics, Gaziantep UniversitySchool of Medicine, Gaziantep, Turkey, 4Department of Rheumatology, Gaziantep University School of Medicine, Gaziantep, Turkey, 5Rheumatology, Uludag University, School of Medicine, Bursa, Turkey, 6Genetcs, Gaziantep UniversitySchool of Medicine, Gaziantep, Turkey

    Background/Purpose Behçet’s Disease (BD) is a systemic vasculitis that predominantly presented with oral aphtous ulcers and additionally at least two of the following findings like…
  • Abstract Number: 2745 • 2014 ACR/ARHP Annual Meeting

    Plasma of Patients with Active Behçet´s Disease (BD) Increases Neutrophil Extracellular Trap Formation, Oxidative Metabolism and NADPH-Oxidase Expression in Normal and BD Neutrophils, and Carries Several Neutrophil Stimulating Factors

    Sandro F. Perazzio1,2, Paulo Vitor Soeiro Pereira3, Alexandre W. S. de Souza1, Antonio Condino-Neto3 and Luis Eduardo C. Andrade2,4, 1Rheumatology, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil, 2Fleury Medicine and Health, Sao Paulo, Brazil, 3Immunology, ICB IV - Universidade de São Paulo, São Paulo, Brazil, 4Fleury Laboratories, Sao Paulo, Brazil

    Background/Purpose Plasma factors seem to play a role in Behçet’s disease (BD) pathogenesis, especially by increasing phagocyte oxidative profile. No data exists regarding neutrophil extracellular…
  • « Previous Page
  • 1
  • …
  • 1867
  • 1868
  • 1869
  • 1870
  • 1871
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology